RIM
REGN icon

Redpoint Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Redpoint Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.76M Sell
2,549
-574
-18% -$361K 0.26% 93
2022
Q2 		$1.85M Hold
3,123
– – 0.22% 108
2022
Q1 		$2.18M Sell
3,123
-48
-2% -$30.4K 0.22% 105
2021
Q4 		$2M Buy
3,171
+110
+4% +$67.6K 0.16% 152
2021
Q3 		$1.85M Sell
3,061
-188
-6% -$117K 0.16% 157
2021
Q2 		$1.81M Sell
3,249
-264
-8% -$134K 0.15% 169
2021
Q1 		$1.66M Buy
3,513
+200
+6% +$97.4K 0.14% 171
2020
Q4 		$1.6M Buy
3,313
+781
+31% +$422K 0.16% 152
2020
Q3 		$1.42M Sell
2,532
-3,230
-56% -$1.96M 0.15% 156
2020
Q2 		$3.59M Sell
5,762
-332
-5% -$188K 0.2% 116
2020
Q1 		$2.98M Hold
6,094
– – 0.19% 133
2019
Q4 		$2.29M Hold
6,094
– – 0.11% 234
2019
Q3 		$1.69M Hold
6,094
– – 0.09% 287
2019
Q2 		$1.91M Sell
6,094
-879
-13% -$293K 0.1% 259
2019
Q1 		$2.86M Buy
6,973
+1,317
+23% +$542K 0.14% 181
2018
Q4 		$2.11M Hold
5,656
– – 0.12% 217
2018
Q3 		$2.29M Hold
5,656
– – 0.12% 221
2018
Q2 		$1.95M Hold
5,656
– – 0.11% 238
2018
Q1 		$1.95M Hold
5,656
– – 0.11% 239
2017
Q4 		$2.13M Buy
+5,656
New +$2.29M 0.12% 231

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Redpoint Investment Management's REGN Position: Q3 2022 in Review

Redpoint Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q3 2022, selling an estimated $361K and leaving 2,549 shares worth $1.76M. The position accounts for 0.26% of the portfolio, ranked #93.

Redpoint Investment Management first reported a position in REGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.59M in Q2 2020. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

  • Redpoint Investment Management held 2,549 shares of Regeneron Pharmaceuticals worth $1.76M as of Q3 2022.
  • Redpoint Investment Management sold 574 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $361K.
  • Regeneron Pharmaceuticals made up 0.26% of Redpoint Investment Management's portfolio in Q3 2022, its #93 holding.
  • Redpoint Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Regeneron Pharmaceuticals position peaked at $3.59M in Q2 2020.
  • 1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.